BRIEF published on 08/12/2025 at 14:35, 8 months 29 days ago MIRA Pharmaceuticals Advances Ketamir-2 for Neuropathic Pain Treatment Pharmaceuticals Clinical Trials Market Growth Ketamir-2 Neuropathic Pain
BRIEF published on 08/12/2025 at 14:35, 8 months 29 days ago MIRA Pharmaceuticals développe le kétamir-2 pour le traitement de la douleur neuropathique Essais Cliniques Croissance Du Marché Médicaments Ketamir-2 Douleur Neuropathique
BRIEF published on 08/12/2025 at 14:20, 8 months 29 days ago ACCESS Newswire Reports Improved Q2 2025 Financial Performance Revenue Growth Operational Efficiency Subscription Model Q2 2025 Results ACCESS Newswire
BRIEF published on 08/12/2025 at 14:20, 8 months 29 days ago ACCESS Newswire annonce une amélioration de ses résultats financiers au deuxième trimestre 2025 Croissance Des Revenus Efficacité Opérationnelle Modèle D'abonnement Résultats Du Deuxième Trimestre 2025 ACCESS Newswire
BRIEF published on 08/12/2025 at 14:05, 8 months 29 days ago Stream Hatchet Collaborates with Ubisoft for Rainbow Six Siege X Launch GameSquare Holdings Stream Hatchet Ubisoft Partnership Rainbow Six Siege X Influencer Strategy
BRIEF published on 08/12/2025 at 14:05, 8 months 29 days ago Stream Hatchet collabore avec Ubisoft pour le lancement de Rainbow Six Siege X GameSquare Holdings Stream Hatchet Rainbow Six Siege X Partenariat Ubisoft Stratégie D'influence
BRIEF published on 08/12/2025 at 14:05, 8 months 29 days ago Troy Minerals Files NI 43-101 Report for High-Purity Silica Resource British Columbia Mineral Exploration Resource Expansion High-purity Silica Economic Studies
BRIEF published on 08/12/2025 at 14:05, 8 months 29 days ago Troy Minerals dépose un rapport NI 43-101 pour une ressource de silice de haute pureté Exploration Minière Colombie-Britannique Expansion Des Ressources Silice De Haute Pureté Études Économiques
BRIEF published on 08/12/2025 at 13:36, 8 months 29 days ago Cardiol Therapeutics: Phase II Trial Results and Positive Stock Outlook BUY Rating Cardiol Therapeutics CardiolRx Phase II ARCHER Trial Acute Myocarditis
BRIEF published on 08/12/2025 at 13:36, 8 months 29 days ago Cardiol Therapeutics : résultats de l'essai de phase II et perspectives boursières positives Cardiol Therapeutics Acheter Une Note CardiolRx Essai ARCHER De Phase II Myocardite Aiguë
Published on 05/09/2026 at 01:30, 1 day 15 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 17 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 1 hour 15 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 3 hours 20 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 5 hours 35 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 22 hours 15 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 20 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 2 days 22 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 22 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 22 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 22 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 22 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
